Real-World Data and Real-World Evidence in Regulatory Decisions
Description
Dr. Jacqueline Corrigan-Curay of the US Food and Drug Administration discusses recent trends in incorporating real-world data and real-world evidence in regulatory decisions.
Speaker
Jaqueline Corrigan-Curay, JD, MD
Principal Deputy Center Director in FDA’s Center for Drug Evaluation and Research (CDER)
Related
View the full Grand Rounds video: Real World Evidence: Contemporary Experience and Future Directions